Notable Stocks in Focus: Key Energy Services Inc. (NYSE:KEG), SunEdison (NYSE:SUNE), Radiant Logistics (NYSEMKT:RLGT), Eagle Bancorp Montana (NASDAQ:EBMT), Mylan (NASDAQ:MYL)


Key Energy Services, Inc. (NYSE:KEG) will report fourth quarter and full-year 2014 financial results after market close on Wednesday, February 18, 2015, and Key management will host a conference call to discuss these results on Thursday, February 19, 2015 at 10:00 a.m. CST. On Monday shares of Key Energy Services Inc. (NYSE:KEG) closed at $2.39. Company’s sales growth for last 5 years was -0.40% and EPS growth for next 5 years is recorded as -11.43%.

SunEdison, Inc. (NYSE: SUNE) Earnings will be released after market close on Wednesday, February 18, 2015.SunEdison, Inc. (NYSE:SUNE) in last trading activity decreased -1.78% to close at $20.36. Company weekly performance is 1.85% while its quarterly performance stands at 10.83%. SunEdison, Inc. (NYSE:SUNE) is -16.39% away from its 52 week high.

Radiant Logistics, Inc. (NYSEMKT:RLGT), will host a conference call on Friday, February 13, at 4:00 PM Eastern to discuss the Company’s financial results for the three and six months ended December 31, 2014. On last trading day Radiant Logistics, Inc. (NYSEMKT:RLGT) decreased -1.73% to close at $4.55. Its volatility for the week is 4.21% while volatility for the month is 4.34%. RLGT’s sales growth for past 5 years was 20.60% and its EPS growth for past 5 years was 19.10%. Radiant Logistics, Inc. (NYSEMKT:RLGT) monthly performance is 6.31%.

On 27 January, Eagle Bancorp Montana, Inc. (NASDAQ:EBMT), reported that net income increased to $924,000, or $0.24 per diluted share, in the quarter ended December 31, 2014. Eagle Bancorp Montana, Inc. (NASDAQ:EBMT) has 7.70% insider ownership while its institutional ownership stands at 37.90%. In last trading activity company’s stock closed at $10.89.

Mylan Inc. (NASDAQ:MYL) confirmed that it and its subsidiary Mylan Pharmaceuticals have been sued by Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals Inc., and Onyx Pharmaceuticals Inc., in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Sorafenib Tablets, 200 mg. On last trading day Mylan, Inc. (NASDAQ:MYL) fell -1.65% to close at $53.00. Its volatility for the week is 2.49% while volatility for the month is 3.16%. MYL’s sales growth for past 5 years was 6.10% and its EPS growth for past 5 years was 28.00%. Mylan, Inc. (NASDAQ:MYL) monthly performance is -6.44%.


Leave a Reply

Your email address will not be published. Required fields are marked *